4.7 Article

The assessment of environmental risk related to the occurrence of pharmaceuticals in bottom sediments of the Odra River estuary (SW Baltic Sea)

Journal

SCIENCE OF THE TOTAL ENVIRONMENT
Volume 828, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.scitotenv.2022.154446

Keywords

Bottom sediments; Environmental risk assessment; Pharmaceutical pollution; Pharmaceuticals in the environment; Odra River estuary

Funding

  1. National Science Centre Poland [OPUS 11, UMO2016/21/B/ST10/02391]
  2. Polish Geological Institute - Polish National Institute [62.9012.1909.00.0]
  3. Medical University of Warsaw

Ask authors/readers for more resources

The occurrence of 130 pharmaceutically active compounds (PhACs) in sediments collected from the Odra River estuary was investigated. The compounds had the highest concentration levels near two main wastewater treatment plants and the seaport and shipyard. Pseudoephedrine, clindamycin, nalidixic acid, carbamazepine, fexofenadine, propranolol, and thiabendazole posed the highest environmental risks.
The occurrence of 130 pharmaceutically active compounds (PhACs) in sediments collected from 70 sampling sites in the Odra River estuary (SW Baltic Sea) was investigated. The highest concentration levels of the compounds were found in the vicinity of effluent discharge from two main Szczecin wastewater treatment plants: Pomorzany and Zdroje, and nearby the seaport and shipyard. The highest environmental risks (RQ > 1) were observed for pseudoephedrine (RQ = 14.0), clindamydn (RQ = 7.3), nalidixic acid (RQ = 3.8), carbamazepine (RQ = 1.8), fexofenadine (RQ = 1.4), propranolol (RQ = 1.1), and thiabendazole (RQ = 1.1). RQ for each compound varied depending on the sampling sites. High environmental risk was observed in 30 sampling sites for clindamycin, 22 sampling sites for pseudoephedrine, 19 sampling sites for nalidixic acid, 4 sampling sites for carbamazepine, and 3 sampling sites for fexofenadine. The medium environmental risk (0.1 < RQ <1) was observed for 16 compounds: arnisulpride, amitriptyline, amlodipine, atropine, bisoprolol, chlorpromazine, lincomycin, metoprolol, mirtazapine, moclobemide, ofloxacin, oxazepam, tiapride, tolperisone, verapamil, and xylometazoline. Due to the scarcity of toxicological data related to benthic organisms, only an approximate assessment of the environmental risk of PhACs is possible. Nevertheless, the compounds with medium and high risk should be considered as pollutants of high environmental concern whose occurrence in the environment should remain under close scrutiny.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available